home / stock / ocul / ocul quote
Last: | $6.17 |
---|---|
Change Percent: | 0.32% |
Open: | $6.25 |
Close: | $6.17 |
High: | $6.26 |
Low: | $6.05 |
Volume: | 1,186,465 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.17 | $6.25 | $6.17 | $6.26 | $6.05 | 1,186,465 | 05-17-2024 |
$6.27 | $6.3 | $6.27 | $6.45 | $5.93 | 3,945,010 | 05-16-2024 |
$6.29 | $6.23 | $6.29 | $6.5999 | $6.225 | 3,678,452 | 05-15-2024 |
$6.05 | $5.83 | $6.05 | $6.16 | $5.811 | 1,982,643 | 05-14-2024 |
$5.64 | $5.68 | $5.64 | $5.93 | $5.56 | 2,314,820 | 05-13-2024 |
$5.66 | $5.9 | $5.66 | $5.95 | $5.35 | 2,175,270 | 05-10-2024 |
$5.84 | $5.71 | $5.84 | $6.08 | $5.6549 | 1,718,298 | 05-09-2024 |
$5.75 | $5.5 | $5.75 | $5.99 | $5.44 | 2,676,950 | 05-08-2024 |
$5.93 | $5.8 | $5.93 | $6.07 | $5.67 | 2,436,694 | 05-07-2024 |
$5.8 | $5.972 | $5.8 | $6.305 | $5.57 | 5,674,315 | 05-06-2024 |
$6.17 | $6.06 | $6.17 | $6.395 | $6.03 | 4,643,067 | 05-03-2024 |
$5.87 | $5.06 | $5.87 | $5.95 | $4.93 | 3,479,674 | 05-02-2024 |
$5.02 | $4.87 | $5.02 | $5.43 | $4.84 | 3,032,532 | 05-01-2024 |
$4.74 | $4.72 | $4.74 | $4.995 | $4.6201 | 2,000,147 | 04-30-2024 |
$4.8 | $4.73 | $4.8 | $5.19 | $4.71 | 3,796,005 | 04-29-2024 |
$4.745 | $4.14 | $4.745 | $4.79 | $4.06 | 3,883,481 | 04-26-2024 |
$4.2 | $4.44 | $4.2 | $4.525 | $4.16 | 4,707,729 | 04-25-2024 |
$4.645 | $5 | $4.645 | $5.01 | $4.56 | 3,949,865 | 04-24-2024 |
$5 | $5.12 | $5 | $5.15 | $4.96 | 2,273,192 | 04-23-2024 |
$5.075 | $5.24 | $5.075 | $5.4699 | $4.98 | 3,745,815 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ocular Therapeutix Inc. Company Name:
OCUL Stock Symbol:
NASDAQ Market:
Ocular Therapeutix Inc. Website:
Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First Subjects Randomized in April 2024 Cash Expected to Support Operations Into 2028, Ba...
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular"), a biopharmaceutical company committed to enh...
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related...